Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68 DOTATATE PET in Prostate Cancer
NCT03448458Phase 2Completed
- Sponsor
- Emory University
- Start
- Feb 2018
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Emory University. Primary endpoint: Gallium Ga 68-DOTATATE Uptake up to 2 hours. Started Feb 2018; status: completed.
Beyond the preview
Go deeper on NCT03448458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448458.